Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study (Q31126033)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1 reference

based on heuristic

inferred from title

author name string

Emilio Esteban

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Noemi Villanueva

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Isabel Muñiz

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Yolanda Fernández

4

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Joaquin Fra

5

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Maria Luque

6

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Paula Jiménez

7

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Beatriz Llorente

8

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Marta Capelan

9

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

José M Vieitez

10

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Enrique Estrada

11

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

José M Buesa

12

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Angel Jiménez-Lacave

13

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

publication date

5 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

67-74

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

https://api.crossref.org/works/10.1007%2FS10637-007-9073-4

21 January 2018

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine-induced pulmonary toxicity: case report and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel and interstitial pulmonary injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical T

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe interstitial pneumonitis associated with docetaxel administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel and gemcitabine combinations in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17805486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-007-9073-4

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31126033&oldid=2195098282"